Vycor Medical (VYCO) EBITDA Margin (2010 - 2026)
Vycor Medical (VYCO) posted quarterly EBITDA Margin of 9.99% for Q1 2026, up 1292.0% year-over-year from 0.72% in Q1 2025, and up 214.02% quarter-over-quarter from 8.76% in Q4 2025.
Vycor Medical (VYCO) EBITDA Margin (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported EBITDA Margin for 17 consecutive years, with 9.99% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 1292.0% year-over-year to 9.99%; the TTM figure through Mar 2026 stood at 4.91% (up 564.0% YoY), while the FY2025 annual figure was 1.82%, up 239.0% from the prior year.
- EBITDA Margin climbed to 9.99% in Q1 2026 per VYCO's latest filing, from 8.76% in the prior quarter.
- Across five years, EBITDA Margin topped out at 19.99% in Q2 2023 and bottomed at 33.62% in Q4 2022.
- Historically, EBITDA Margin has averaged 5.3% across 5 years, with a median of 2.93% in 2025.
- On a YoY basis, EBITDA Margin climbed as much as 5308 bps in 2022 and fell as far as 2746 bps in 2022.
- Vycor Medical's EBITDA Margin stood at 33.62% in 2022, then surged by 38 bps to 20.78% in 2023, then jumped by 120 bps to 4.25% in 2024, then plunged by 306 bps to 8.76% in 2025, then soared by 214 bps to 9.99% in 2026.
- Business Quant data shows VYCO's EBITDA Margin at 9.99% in Q1 2026, 8.76% in Q4 2025, and 6.24% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 1.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.99% |
| Dec 31, 2025 | -8.76% |
| Sep 30, 2025 | 6.24% |
| Jun 30, 2025 | 10.30% |
| Mar 31, 2025 | -2.93% |
| Dec 31, 2024 | 4.25% |
| Sep 30, 2024 | -8.99% |
| Jun 30, 2024 | 3.98% |
| Mar 31, 2024 | -2.83% |
| Dec 31, 2023 | -20.78% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | 19.99% |
| Mar 31, 2023 | 9.20% |
| Dec 31, 2022 | -33.62% |
| Sep 30, 2022 | -28.40% |
| Jun 30, 2022 | -22.68% |
| Mar 31, 2022 | -16.86% |
| Dec 31, 2021 | -59.99% |
| Sep 30, 2021 | -26.62% |
| Jun 30, 2021 | 4.78% |